{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:23:26Z","timestamp":1707524606373},"reference-count":70,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,1]]},"DOI":"10.7759\/cureus.23744","type":"journal-article","created":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T19:21:25Z","timestamp":1648840885000},"source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic Difficulties and Treatment Challenges of a Young Patient With Severe Acute Psychosis and Complete Recovery"],"prefix":"10.7759","author":[{"given":"Jagoda","family":"Siembida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saaduddin","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariam","family":"Chishty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luba","family":"Leontieva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Marijuana and public health. data and statistics. (2021). Accessed: October 3, 2021: https:\/\/www.cdc.gov\/marijuana\/data-statistics.htm."},{"key":"ref2","unstructured":"Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: results from the 2019 national survey on drug use and health. (2019). Accessed: October 3, 2021: https:\/\/store.samhsa.gov\/product\/key-substance-use-and-mental-health-indicators-in-the-united-states-results-from-the...."},{"key":"ref3","unstructured":"National Institute on Drug Abuse. Vaping and cannabis trends among young adults (19-22). (2021). Accessed: October 3, 2021: https:\/\/www.drugabuse.gov\/sites\/default\/files\/nida2019collegemtfinfographic.pdf."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.31887\/DCNS.2017.19.3\/glafaye","article-title":"Cannabis, cannabinoids, and health","volume":"19","author":"Lafaye G","year":"2017","unstructured":"Lafaye G, Karila L, Blecha L, Benyamina A. Cannabis, cannabinoids, and health. Dialogues Clin Neurosci. 2017, 19:309-16. 10.31887\/DCNS.2017.19.3\/glafaye","journal-title":"Dialogues Clin Neurosci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2016.01.004","article-title":"Changes in cannabis potency over the last 2 decades (1995-2014): analysis of current data in the United States","volume":"79","author":"ElSohly MA","year":"2016","unstructured":"ElSohly MA, Mehmedic Z, Foster S, Gon C, Chandra S, Church JC. Changes in cannabis potency over the last 2 decades (1995-2014): analysis of current data in the United States. Biol Psychiatry. 2016, 79:613-9. 10.1016\/j.biopsych.2016.01.004","journal-title":"Biol Psychiatry"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.109.064220","article-title":"High-potency cannabis and the risk of psychosis","volume":"195","author":"Di Forti M","year":"2009","unstructured":"Di Forti M, Morgan C, Dazzan P, et al.. High-potency cannabis and the risk of psychosis. Br J Psychiatry. 2009, 195:488-91. 10.1192\/bjp.bp.109.064220","journal-title":"Br J Psychiatry"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaac.2019.10.003","article-title":"Editorial: brain mediators of the cannabis-prodromal psychosis connection","volume":"59","author":"Lange N","year":"2020","unstructured":"Lange N. Editorial: brain mediators of the cannabis-prodromal psychosis connection. J Am Acad Child Adolesc Psychiatry. 2020, 59:592-4. 10.1016\/j.jaac.2019.10.003","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbw003","article-title":"Meta-analysis of the association between the level of cannabis use and risk of psychosis","volume":"42","author":"Marconi A","year":"2016","unstructured":"Marconi A, Di Forti M, Lewis CM, Murray RM, Vassos E. Meta-analysis of the association between the level of cannabis use and risk of psychosis. Schizophr Bull. 2016, 42:1262-9. 10.1093\/schbul\/sbw003","journal-title":"Schizophr Bull"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","article-title":"Diagnostic and statistical manual of mental disorders, fifth edition","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders, fifth edition. American Psychiatric Association, 2013. 10.1176\/appi.books.9780890425596"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2016.02.005","article-title":"Cannabis and psychosis: what degree of proof do we require?","volume":"79","author":"Murray RM","year":"2016","unstructured":"Murray RM, Di Forti M. Cannabis and psychosis: what degree of proof do we require?. Biol Psychiatry. 2016, 79:514-5. 10.1016\/j.biopsych.2016.02.005","journal-title":"Biol Psychiatry"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2015.219","article-title":"AKT1 genotype moderates the acute psychotomimetic effects of naturalistically smoked cannabis in young cannabis smokers","volume":"6","author":"Morgan CJ","year":"2016","unstructured":"Morgan CJ, Freeman TP, Powell J, Curran HV. AKT1 genotype moderates the acute psychotomimetic effects of naturalistically smoked cannabis in young cannabis smokers. Transl Psychiatry. 2016, 6:e738. 10.1038\/tp.2015.219","journal-title":"Transl Psychiatry"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2019.18101217","article-title":"Prediction of onset of substance-induced psychotic disorder and its progression to schizophrenia in a Swedish national sample","volume":"176","author":"Kendler KS","year":"2019","unstructured":"Kendler KS, Ohlsson H, Sundquist J, Sundquist K. Prediction of onset of substance-induced psychotic disorder and its progression to schizophrenia in a Swedish national sample. Am J Psychiatry. 2019, 176:711-9. 10.1176\/appi.ajp.2019.18101217","journal-title":"Am J Psychiatry"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-019-1044-x","article-title":"Cannabis and psychosis: are we any closer to understanding the relationship?","volume":"21","author":"Hamilton I","year":"2019","unstructured":"Hamilton I, Monaghan M. Cannabis and psychosis: are we any closer to understanding the relationship?. Curr Psychiatry Rep. 2019, 21:48. 10.1007\/s11920-019-1044-x","journal-title":"Curr Psychiatry Rep"},{"key":"ref14","article-title":"Tobacco product use among adults","volume":"69","author":"Cornelius ME","year":"2020","unstructured":"Cornelius ME, Wang TW, Jamal A, Loretan CG, Neff LJ. Tobacco product use among adults. Morb Mortal Wkly Rep. 2020, 69:1736-42.","journal-title":"Morb Mortal Wkly Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntx284","article-title":"E-cigarette marketing and communication: how e-cigarette companies market e-cigarettes and the public engages with e-cigarette information","volume":"21","author":"Collins L","year":"2019","unstructured":"Collins L, Glasser AM, Abudayyeh H, Pearson JL, Villanti AC. E-cigarette marketing and communication: how e-cigarette companies market e-cigarettes and the public engages with e-cigarette information. Nicotine Tob Res. 2019, 21:14-24. 10.1093\/ntr\/ntx284","journal-title":"Nicotine Tob Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-020-09572-x","article-title":"E-cigarettes use in the United States: reasons for use, perceptions, and effects on health","volume":"20","author":"Sapru S","year":"2020","unstructured":"Sapru S, Vardhan M, Li Q, Guo Y, Li X, Saxena D. E-cigarettes use in the United States: reasons for use, perceptions, and effects on health. BMC Public Health. 2020, 20:1518. 10.1186\/s12889-020-09572-x","journal-title":"BMC Public Health"},{"key":"ref17","unstructured":"Outbreak of lung injury associated with the use of e-cigarette, or vaping products. (2021). Accessed. September 2, 2021: https:\/\/www.cdc.gov\/tobacco\/basic_information\/e-cigarettes\/severe-lung-disease.html."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2015.11.008","article-title":"Psychiatric comorbidity in adolescent electronic and conventional cigarette use","volume":"73","author":"Leventhal AM","year":"2016","unstructured":"Leventhal AM, Strong DR, Sussman S, Kirkpatrick MG, Unger JB, Barrington-Trimis JL, Audrain-McGovern J. Psychiatric comorbidity in adolescent electronic and conventional cigarette use. J Psychiatr Res. 2016, 73:71-8. 10.1016\/j.jpsychires.2015.11.008","journal-title":"J Psychiatr Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2014-0760","article-title":"Risk factors for exclusive e-cigarette use and dual e-cigarette use and tobacco use in adolescents","volume":"135","author":"Wills TA","year":"2015","unstructured":"Wills TA, Knight R, Williams RJ, Pagano I, Sargent JD. Risk factors for exclusive e-cigarette use and dual e-cigarette use and tobacco use in adolescents. Pediatrics. 2015, 135:43-51. 10.1542\/peds.2014-0760","journal-title":"Pediatrics"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1177\/2045125319859969","article-title":"The relationship between nicotine and psychosis","volume":"9","author":"Quigley H","year":"2019","unstructured":"Quigley H, MacCabe JH. The relationship between nicotine and psychosis. Ther Adv Psychopharmacol. 2019, 9:1-12. 10.1177\/2045125319859969","journal-title":"Ther Adv Psychopharmacol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1177\/0269881114563634","article-title":"Glutamate and dopamine in schizophrenia: an update for the 21st century","volume":"29","author":"Howes O","year":"2015","unstructured":"Howes O, McCutcheon R, Stone J. Glutamate and dopamine in schizophrenia: an update for the 21st century. J Psychopharmacol. 2015, 29:97-115. 10.1177\/0269881114563634","journal-title":"J Psychopharmacol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/5710810","article-title":"Acute psychoasis in withdrawal from nicotine vaping in a young man with comorbid diabetic ketoacidosis and cannabis use","volume":"2020","author":"Rutledge KJ","year":"2020","unstructured":"Rutledge KJ, Plath DL. Acute psychoasis in withdrawal from nicotine vaping in a young man with comorbid diabetic ketoacidosis and cannabis use. Case Rep Psychiatry. 2020, 2020:5710810. 10.1155\/2020\/5710810","journal-title":"Case Rep Psychiatry"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2010.09071043","article-title":"Identification and treatment of a pineal region tumor in an adolescent with prodromal psychotic symptoms","volume":"167","author":"Mittal VA","year":"2010","unstructured":"Mittal VA, Karlsgodt K, Zinberg J, Cannon TD, Bearden CE. Identification and treatment of a pineal region tumor in an adolescent with prodromal psychotic symptoms. Am J Psychiatry. 2010, 167:1033-7. 10.1176\/appi.ajp.2010.09071043","journal-title":"Am J Psychiatry"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1023\/a:1012771204732","article-title":"Epidemiology of germ cell tumors in Asia of pineal region tumor","volume":"54","author":"Nomura K","year":"2001","unstructured":"Nomura K. Epidemiology of germ cell tumors in Asia of pineal region tumor. J Neurooncol. 2001, 54:211-7. 10.1023\/a:1012771204732","journal-title":"J Neurooncol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/BF02011087","article-title":"The pineal gland: a comparative MR imaging study in children and adults with respect to normal anatomical variations and pineal cysts","volume":"25","author":"Sener RN","year":"1995","unstructured":"Sener RN. The pineal gland: a comparative MR imaging study in children and adults with respect to normal anatomical variations and pineal cysts. Pediatr Radiol. 1995, 25:245-8. 10.1007\/BF02011087","journal-title":"Pediatr Radiol"},{"key":"ref26","article-title":"Benign glial cysts of the pineal gland: unusual imaging characteristics with histologic correlation","volume":"15","author":"Fleege MA","year":"1994","unstructured":"Fleege MA, Miller GM, Fletcher GP, Fain JS, Scheithauer BW. Benign glial cysts of the pineal gland: unusual imaging characteristics with histologic correlation. AJNR Am J Neuroradiol. 1994, 15:161-6.","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3109\/00207459209000549","article-title":"Pineal calcification and its relationship to hallucinations in schizophrenia","volume":"64","author":"Sandyk R","year":"1992","unstructured":"Sandyk R, Kay SR. Pineal calcification and its relationship to hallucinations in schizophrenia. Int J Neurosci. 1992, 64:217-9. 10.3109\/00207459209000549","journal-title":"Int J Neurosci"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(13)70282-5","article-title":"Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study","volume":"13","author":"Gresa-Arribas N","year":"2014","unstructured":"Gresa-Arribas N, Titulaer MJ, Torrents A, et al.. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol. 2014, 13:167-77. 10.1016\/S1474-4422(13)70282-5","journal-title":"Lancet Neurol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1192\/pb.bp.113.045518","article-title":"Anti-N-methyl-d-aspartate receptor encephalitis: review of clinical presentation, diagnosis and treatment","volume":"39","author":"Barry H","year":"2015","unstructured":"Barry H, Byrne S, Barrett E, Murphy KC, Cotter DR. Anti-N-methyl-d-aspartate receptor encephalitis: review of clinical presentation, diagnosis and treatment. BJPsych Bull. 2015, 39:19-23. 10.1192\/pb.bp.113.045518","journal-title":"BJPsych Bull"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.2069","article-title":"Retrospective study on structural neuroimaging in first-episode psychosis","volume":"4","author":"Coentre R","year":"2016","unstructured":"Coentre R, Silva-Dos-Santos A, Talina MC. Retrospective study on structural neuroimaging in first-episode psychosis. PeerJ. 2016, 4:e2069. 10.7717\/peerj.2069","journal-title":"PeerJ"},{"key":"ref31","article-title":"Pineal gland volume in schizophrenia and mood disorders","volume":"27","author":"F\u0131nd\u0131kl\u0131 E","year":"2015","unstructured":"F\u0131nd\u0131kl\u0131 E, Inci MF, G\u00f6k\u00e7e M, F\u0131nd\u0131kl\u0131 HA, Altun H, Karaaslan MF. Pineal gland volume in schizophrenia and mood disorders. Psychiatr Danub. 2015, 27:153-8.","journal-title":"Psychiatr Danub"},{"key":"ref32","article-title":"A case of hyper sexuality probably associated with clozapine","volume":"48","author":"Thomson SR","year":"2018","unstructured":"Thomson SR, Patil N, Ommurugan B, Bhandary RK. A case of hyper sexuality probably associated with clozapine. Psychopharmacol Bull. 2018, 48:20-4.","journal-title":"Psychopharmacol Bull"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbv001","article-title":"The facts about sexual (dys)function in schizophrenia: an overview of clinically relevant findings","volume":"41","author":"de Boer MK","year":"2015","unstructured":"de Boer MK, Castelein S, Wiersma D, Schoevers RA, Knegtering H. The facts about sexual (dys)function in schizophrenia: an overview of clinically relevant findings. Schizophr Bull. 2015, 41:674-86. 10.1093\/schbul\/sbv001","journal-title":"Schizophr Bull"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.00318","article-title":"Recurrent episodes of paraphilic behavior possibly associated with olanzapine and aripiprazole treatment in a patient with schizophrenia","volume":"11","author":"Stefanou MI","year":"2020","unstructured":"Stefanou MI, Vittore D, Wolz I, Klingberg S, Wildgruber D. Recurrent episodes of paraphilic behavior possibly associated with olanzapine and aripiprazole treatment in a patient with schizophrenia. Front Psychiatry. 2020, 11:318. 10.3389\/fpsyt.2020.00318","journal-title":"Front Psychiatry"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1007\/s10508-009-9574-7","article-title":"Hypersexual disorder: a proposed diagnosis for DSM-V","volume":"39","author":"Kafka MP","year":"2010","unstructured":"Kafka MP. Hypersexual disorder: a proposed diagnosis for DSM-V. Arch Sex Behav. 2010, 39:377-400. 10.1007\/s10508-009-9574-7","journal-title":"Arch Sex Behav"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.57.11.1012","article-title":"The neurobiology of sexual function","volume":"57","author":"Meston CM","year":"2000","unstructured":"Meston CM, Frohlich PF. The neurobiology of sexual function. Arch Gen Psychiatry. 2000, 57:1012-30. 10.1001\/archpsyc.57.11.1012","journal-title":"Arch Gen Psychiatry"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aws326","article-title":"Neural response to visual sexual cues in dopamine treatment-linked hypersexuality in Parkinson's disease","volume":"136","author":"Politis M","year":"2013","unstructured":"Politis M, Loane C, Wu K, et al.. Neural response to visual sexual cues in dopamine treatment-linked hypersexuality in Parkinson's disease. Brain. 2013, 136:400-11. 10.1093\/brain\/aws326","journal-title":"Brain"},{"key":"ref38","article-title":"Hypersexual disorder-a case report and analysis","volume":"1","author":"Sarangi A","year":"2017","unstructured":"Sarangi A, Morgan K\r\n. Hypersexual disorder-a case report and analysis. Clin Med Case Rep. 2017, 1:113.","journal-title":"Clin Med Case Rep"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000934","article-title":"A case of hypersexuality probably associated with lurasidone","volume":"38","author":"Reddy B","year":"2018","unstructured":"Reddy B, Das S, Ali M. A case of hypersexuality probably associated with lurasidone. J Clin Psychopharmacol. 2018, 38:537-9. 10.1097\/JCP.0000000000000934","journal-title":"J Clin Psychopharmacol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.4306\/pi.2013.10.2.200","article-title":"Two cases of hypersexuality probably associated with aripiprazole","volume":"10","author":"Cheon E","year":"2013","unstructured":"Cheon E, Koo BH, Seo SS, Lee JY. Two cases of hypersexuality probably associated with aripiprazole. Psychiatry Investig. 2013, 10:200-2. 10.4306\/pi.2013.10.2.200","journal-title":"Psychiatry Investig"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2017.10.008","article-title":"Hypersexuality induced by aripiprazole: two case reports and review of the literature","volume":"38","author":"Reddy B","year":"2018","unstructured":"Reddy B, Ali M, Guruprasad S, Das S. Hypersexuality induced by aripiprazole: two case reports and review of the literature. Asian J Psychiatr. 2018, 38:57-9. 10.1016\/j.ajp.2017.10.008","journal-title":"Asian J Psychiatr"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199808000-00023","article-title":"Olanzapine-induced reversible priaprism: a case report","volume":"18","author":"Deirmenjian JM","year":"1998","unstructured":"Deirmenjian JM, Erhart SM, Wirshing DA, Spellberg BJ, Wirshing WC. Olanzapine-induced reversible priaprism: a case report. J Clin Psychopharmacol. 1998, 18:351-3. 10.1097\/00004714-199808000-00023","journal-title":"J Clin Psychopharmacol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0000000000000143","article-title":"Spontaneous ejaculations in an adolescent with olanzapine use: case report","volume":"39","author":"Yekta\u015f \u00c7","year":"2016","unstructured":"Yekta\u015f \u00c7, Tufan AE. Spontaneous ejaculations in an adolescent with olanzapine use: case report. Clinical neuropharmacology. 2016, 39:157-8. 10.1097\/WNF.0000000000000143","journal-title":"Clinical neuropharmacology"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/596898","article-title":"Second generation antipsychotics improve sexual dysfunction in schizophrenia: a randomised controlled trial","volume":"2011","author":"Mahmoud A","year":"2011","unstructured":"Mahmoud A, Hayhurst KP, Drake RJ, Lewis SW. Second generation antipsychotics improve sexual dysfunction in schizophrenia: a randomised controlled trial. Schizophr Res Treatment. 2011, 2011:596898. 10.1155\/2011\/596898","journal-title":"Schizophr Res Treatment"},{"key":"ref45","article-title":"Future research needs for first- and second-generation antipsychotics for children and young adults","author":"Christian R","year":"2012","unstructured":"Christian R, Saavedra L, Gaynes BN, et al.. Future research needs for first- and second-generation antipsychotics for children and young adults. Agency for Healthcare Research and Quality, US; 2012."},{"key":"ref46","unstructured":"FDA approves Caplyta to treat schizophrenia in adults. (2019). Accessed. October, 2021: https:\/\/www.mdedge.com\/psychiatry\/article\/214733\/schizophrenia-other-psychotic-disorders\/fda-approves-caplyta-treat."},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1177\/026988110101500403","article-title":"Determining the optimal dose of haloperidol in first-episode psychosis","volume":"15","author":"Oosthuizen P","year":"2001","unstructured":"Oosthuizen P, Emsley RA, Turner J, Keyter N. Determining the optimal dose of haloperidol in first-episode psychosis. J Psychopharmacol. 2001, 15:251-5. 10.1177\/026988110101500403","journal-title":"J Psychopharmacol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyaa004","article-title":"Antipsychotic treatment effectiveness in first episode of psychosis: PAFIP 3-year follow-up randomized clinical trials comparing haloperidol, olanzapine, risperidone, aripiprazole, quetiapine, and ziprasidone","volume":"23","author":"G\u00f3mez-Revuelta M","year":"2020","unstructured":"G\u00f3mez-Revuelta M, Pelayo-Ter\u00e1n JM, Juncal-Ruiz M, et al.. Antipsychotic treatment effectiveness in first episode of psychosis: PAFIP 3-year follow-up randomized clinical trials comparing haloperidol, olanzapine, risperidone, aripiprazole, quetiapine, and ziprasidone. Int J Neuropsychopharmacol. 2020, 23:217-29. 10.1093\/ijnp\/pyaa004","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009268.pub2","article-title":"Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia","volume":"7","author":"Tardy M","year":"2014","unstructured":"Tardy M, Huhn M, Kissling W, Engel RR, Leucht S. Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia. Cochrane Database Syst Rev. 2014, 7:CD009268. 10.1002\/14651858.CD009268.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009831.pub2","article-title":"Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders","volume":"1","author":"Dold M","year":"2015","unstructured":"Dold M, Samara MT, Li C, Tardy M, Leucht S. Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders. Cochrane Database Syst Rev. 2015, 1:CD009831. 10.1002\/14651858.CD009831.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.156.1.79","article-title":"Olanzapine versus haloperidol treatment in first-episode psychosis","volume":"156","author":"Sanger TM","year":"1999","unstructured":"Sanger TM, Lieberman JA, Tohen M, Grundy S, Beasley C Jr, Tollefson GD. Olanzapine versus haloperidol treatment in first-episode psychosis. Am J Psychiatry. 1999, 156:79-87. 10.1176\/ajp.156.1.79","journal-title":"Am J Psychiatry"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1124\/pr.111.005512","article-title":"Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder","volume":"65","author":"Chiu CT","year":"2013","unstructured":"Chiu CT, Wang Z, Hunsberger JG, Chuang DM. Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder. Pharmacol Rev. 2013, 65:105-42. 10.1124\/pr.111.005512","journal-title":"Pharmacol Rev"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002475","article-title":"Significant effect of valproate augmentation therapy in patients with schizophrenia: a meta-analysis study","volume":"95","author":"Tseng PT","year":"2016","unstructured":"Tseng PT, Chen YW, Chung W, Tu KY, Wang HY, Wu CK, Lin PY. Significant effect of valproate augmentation therapy in patients with schizophrenia: a meta-analysis study. Medicine. 2016, 95:e2475. 10.1097\/MD.0000000000002475","journal-title":"Medicine"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004028.pub4","article-title":"Valproate for schizophrenia","volume":"11","author":"Wang Y","year":"2016","unstructured":"Wang Y, Xia J, Helfer B, Li C, Leucht S. Valproate for schizophrenia. Cochrane Database Syst Rev. 2016, 11:CD004028. 10.1002\/14651858.CD004028.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1186\/s40345-021-00238-0","article-title":"Characterization of affective lability across subgroups of psychosis spectrum disorders","volume":"9","author":"H\u00f8egh MC","year":"2021","unstructured":"H\u00f8egh MC, Melle I, Aminoff SR, et al.. Characterization of affective lability across subgroups of psychosis spectrum disorders. Int J Bipolar Disord. 2021, 9:34. 10.1186\/s40345-021-00238-0","journal-title":"Int J Bipolar Disord"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-236940","article-title":"COVID-19-associated brief psychotic disorder","volume":"13","author":"Smith CM","year":"2020","unstructured":"Smith CM, Komisar JR, Mourad A, Kincaid BR. COVID-19-associated brief psychotic disorder. BMJ Case Rep. 2020, 13:e236940. 10.1136\/bcr-2020-236940","journal-title":"BMJ Case Rep"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1919.02610040001001","article-title":"Psychoses associated with influenza: I. General data: statistical analysis","volume":"72","author":"Menninger KA","year":"1919","unstructured":"Menninger KA. Psychoses associated with influenza: I. General data: statistical analysis. JAMA. 1919, 72:235-241. 10.1001\/jama.1919.02610040001001","journal-title":"JAMA"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1007\/s42399-020-00530-7","article-title":"Covid-19-induced psychosis and suicidal behavior: case report","volume":"2","author":"Chacko M","year":"2020","unstructured":"Chacko M, Job A, Caston F 3rd, George P, Yacoub A, C\u00e1ceda R. Covid-19-induced psychosis and suicidal behavior: case report. SN Compr Clin Med. 2020, 2:2391-5. 10.1007\/s42399-020-00530-7","journal-title":"SN Compr Clin Med"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-242538","article-title":"New-onset psychosis due to COVID-19","volume":"14","author":"Kozato N","year":"2021","unstructured":"Kozato N, Mishra M, Firdosi M. New-onset psychosis due to COVID-19. BMJ Case Rep. 2021, 14:e242538. 10.1136\/bcr-2021-242538","journal-title":"BMJ Case Rep"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2020.07.042","article-title":"Letter to the editor: new onset psychosis and mania following COVID-19 infection","volume":"130","author":"Noone R","year":"2020","unstructured":"Noone R, Cabassa JA, Gardner L, Schwartz B, Alpert JE, Gabbay V. Letter to the editor: new onset psychosis and mania following COVID-19 infection. J Psychiatr Res. 2020, 130:177-9. 10.1016\/j.jpsychires.2020.07.042","journal-title":"J Psychiatr Res"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.184.4.359","article-title":"Psychiatric complications in patients with severe acute respiratory syndrome (SARS) during the acute treatment phase: a series of 10 cases","volume":"184","author":"Cheng SK","year":"2004","unstructured":"Cheng SK, Tsang JS, Ku KH, Wong CW, Ng YK. Psychiatric complications in patients with severe acute respiratory syndrome (SARS) during the acute treatment phase: a series of 10 cases. Br J Psychiatry. 2004, 184:359-60. 10.1192\/bjp.184.4.359","journal-title":"Br J Psychiatry"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1186\/s41983-021-00379-0","article-title":"Neurological sequelae of COVID-19: a review","volume":"57","author":"Peterson CJ","year":"2021","unstructured":"Peterson CJ, Sarangi A, Bangash F. Neurological sequelae of COVID-19: a review. Egypt J Neurol Psychiatr Neurosurg. 2021, 57:122. 10.1186\/s41983-021-00379-0","journal-title":"Egypt J Neurol Psychiatr Neurosurg"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.12746\/swrccc.v8i35.727","article-title":"The psychiatric effects of COVID-19 thus far: a review of the current literature","volume":"8","author":"Wright K","year":"2020","unstructured":"Wright K, Sarangi A, Ibrahim Y. The psychiatric effects of COVID-19 thus far: a review of the current literature. Southwest Respir Crit Care Chron. 2020, 8:17-28. 10.12746\/swrccc.v8i35.727","journal-title":"Southwest Respir Crit Care Chron"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2008.5","article-title":"Are some cases of psychosis caused by microbial agents? A review of the evidence","volume":"13","author":"Yolken RH","year":"2008","unstructured":"Yolken RH, Torrey EF. Are some cases of psychosis caused by microbial agents? A review of the evidence. Mol Psychiatry. 2008, 13:470-9. 10.1038\/mp.2008.5","journal-title":"Mol Psychiatry"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(94)90615-7","article-title":"Viral antibodies in recent onset, nonorganic psychoses: correspondence with symptomatic severity","volume":"36","author":"Srikanth S","year":"1994","unstructured":"Srikanth S, Ravi V, Poornima KS, et al.. Viral antibodies in recent onset, nonorganic psychoses: correspondence with symptomatic severity. Biol Psychiatry. 1994, 36:517-21. 10.1016\/0006-3223(94)90615-7","journal-title":"Biol Psychiatry"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sby021","article-title":"Antibodies in the diagnosis, prognosis, and prediction of psychotic disorders","volume":"45","author":"Pollak TA","year":"2019","unstructured":"Pollak TA, Rogers JP, Nagele RG, Peakman M, Stone JM, David AS, McGuire P. Antibodies in the diagnosis, prognosis, and prediction of psychotic disorders. Schizophr Bull. 2019, 45:233-46. 10.1093\/schbul\/sby021","journal-title":"Schizophr Bull"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2020.04.027","article-title":"Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms","volume":"87","author":"Troyer EA","year":"2020","unstructured":"Troyer EA, Kohn JN, Hong S. Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms. Brain Behav Immun. 2020, 87:34-9. 10.1016\/j.bbi.2020.04.027","journal-title":"Brain Behav Immun"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2006.01.049","article-title":"Human coronavirus OC43 infection induces chronic encephalitis leading to disabilities in BALB\/C mice","volume":"349","author":"Jacomy H","year":"2006","unstructured":"Jacomy H, Fragoso G, Almazan G, Mushynski WE, Talbot PJ. Human coronavirus OC43 infection induces chronic encephalitis leading to disabilities in BALB\/C mice. Virology. 2006, 349:335-46. 10.1016\/j.virol.2006.01.049","journal-title":"Virology"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1016\/j.psym.2020.05.012","article-title":"COVID-19 psychosis: a potential new neuropsychiatric condition triggered by novel coronavirus infection and the inflammatory response?","volume":"61","author":"Ferrando SJ","year":"2020","unstructured":"Ferrando SJ, Klepacz L, Lynch S, et al.. COVID-19 psychosis: a potential new neuropsychiatric condition triggered by novel coronavirus infection and the inflammatory response?. Psychosomatics. 2020, 61:551-5. 10.1016\/j.psym.2020.05.012","journal-title":"Psychosomatics"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0250815","article-title":"Hypertension as a sequela in patients of SARS-CoV-2 infection","volume":"16","author":"Chen G","year":"2021","unstructured":"Chen G, Li X, Gong Z, et al.. Hypertension as a sequela in patients of SARS-CoV-2 infection. PLoS One. 2021, 16:e0250815. 10.1371\/journal.pone.0250815","journal-title":"PLoS One"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/87990-diagnostic-difficulties-and-treatment-challenges-of-a-young-patient-with-severe-acute-psychosis-and-complete-recovery","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:36:44Z","timestamp":1707507404000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/87990-diagnostic-difficulties-and-treatment-challenges-of-a-young-patient-with-severe-acute-psychosis-and-complete-recovery"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,1]]},"references-count":70,"URL":"https:\/\/doi.org\/10.7759\/cureus.23744","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,1]]}}}